Advanced Well-differentiated Pancreatic Neuroendocrine Tumor

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced Well-differentiated Pancreatic Neuroendocrine Tumor trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05477576

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 17…

This study aims to determine the safety, pharmacokinetics (PK) and recommended Phase 3 dose (RP3D) of RYZ101 in Part 1, and the safety, efficacy, and PK of RYZ1…

United States338 participantsStarted 2022-03-24

Treatment: RYZ101, Everolimus

All recent trials (25 shown)

CompletedNot Applicable

NCT04727723

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in…

This is a multicentre long-term non-interventional study of adult subjects diagnosed with unresectable or metastatic, progressive, well differentiated (G1 and G…

Italy164 participantsStarted 2021-03-09

Treatment: Lutathera®

Active — Not RecruitingPhase 2

NCT02595424

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Sm…

This randomized phase II trial studies how well temozolomide and capecitabine work compared to standard treatment with cisplatin or carboplatin and etoposide in…

United States67 participantsStarted 2015-11-06

Treatment: Capecitabine, Carboplatin

Advanced Well-differentiated Pancreatic Neuroendocrine Tumor

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 17…

All recent trials (25 shown)

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in…

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Sm…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 17…

All recent trials (25 shown)

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in…

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Sm…

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering Fro…

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic…

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a…

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unr…

Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previous…

Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neur…

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership…

Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib

Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine…

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor